logo

Sage Therapeutics, Inc. (SAGE)



Trade SAGE now with
  Date
  Headline
8/3/2021 6:47:10 AM Sage Therapeutics Q2 Net Loss $107.2 Mln Vs. Net Loss Of $136.3 Mln Prior Year
4/12/2021 7:04:20 AM Sage Therapeutics, Biogen: Phase 2 KINETIC Study Of SAGE-324 In Essential Tremor Meets Primary Endpoint
11/27/2017 12:02:55 PM RBC Capital Markets Is Raising SAGE Therapeutics, Inc. (SAGE) FY19 Rev. Estimate To 172.8 M From 165.3 M
11/27/2017 12:02:36 PM RBC Capital Markets Is Increasing SAGE Therapeutics, Inc. (SAGE) FY18 Rev. Estimate To 83.8 M From 76.3 M
11/27/2017 12:02:03 PM RBC Capital Markets Is Raising SAGE Therapeutics, Inc. (SAGE) FY19 Estimate To -5.92 From -6.17
11/27/2017 12:01:45 PM RBC Capital Markets Is Raising SAGE Therapeutics, Inc. (SAGE) FY18 Estimate To -6.28 From -6.55
11/27/2017 12:01:26 PM RBC Capital Markets Is Raising SAGE Therapeutics, Inc. (SAGE) FY17 Estimate To -7.19 From -7.22
11/27/2017 12:01:07 PM RBC Capital Markets Is Increasing SAGE Therapeutics, Inc. (SAGE) Q4 17 Estimate To -1.81 From -1.85
2/9/2016 10:48:20 AM Canaccord Is Increasing SAGE Therapeutics, Inc. (SAGE) 2016 Estimate To -3.62 From -4.72
3/20/2015 11:07:06 AM William Blair Initiates SAGE Therapeutics, Inc. (SAGE) At Outperform